---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-019384"
form_type: "8-K"
ticker: "SILO"
cik: "0001514183"
company_name: "Silo Pharma, Inc."
filed_at: "2026-02-23T23:59:59+00:00"
generated_at: "2026-05-16T01:07:57.718148+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Silo Pharma authorizes $1M buyback; pays IR consultant 848k shares

## Summary
- Board approved stock repurchase program up to $1 million of common stock.
- Shares outstanding: 13,318,273 as of Sept 30, 2025.
- Issued 848,320 shares to IR consultant as $250k commitment fee at $0.2947/share.
- No proceeds received; shares issued under Section 4(a)(2) exemption.
- Buyback discretionary; may be suspended or discontinued anytime.

## SEC filing metadata
- accession: 0001213900-26-019384
- form_type: 8-K
- ticker: SILO
- cik: 0001514183
- company_name: Silo Pharma, Inc.
- filed_at: 2026-02-23T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1514183/000121390026019384/0001213900-26-019384-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1514183/000121390026019384/ea0278025-8k_silo.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-019384
- JSON: https://secwatch.observer/filing/0001213900-26-019384.json
- Plain text: https://secwatch.observer/filing/0001213900-26-019384.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.